Tenaya Therapeutics Inc

NASDAQ: TNYA
$3.57
+$0.28 (+8.5%)
Closing Price on November 29, 2024

TNYA Stock Chart and Intraday Price

TNYA Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 513.59M USD
Shares Outstanding 77,000,000
Based in South San Francisco, California, Tenaya Therapeutics is at the forefront of biotechnology with a focus on developing innovative therapies for heart disease. Leveraging cutting-edge platforms in cellular regeneration, gene therapy, and precision medicine, Tenaya is working on a range of treatments. These include gene therapies for specific types of cardiomyopathy and a small molecule for heart failure, alongside pioneering efforts in cardiac regeneration to help patients recover from heart failure caused by myocardial infarction. Founded in 2016, Tenaya aims to transform the landscape of cardiovascular disease treatment.

TNYA Articles

Penny stocks represent an interesting investment opportunity. These stocks typically represent small companies or companies that are early in the development stages. But isn’t that how you make it...
A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.